A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
Clinical trial NCT05805501 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05805501
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-21
- Primary completion
- 2026-10-08
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.